127 related articles for article (PubMed ID: 36065495)
1. Exploring the Gallic and Cinnamic Acids Chimeric Derivatives as Anticancer Agents over HeLa Cell Line: An in silico and in vitro Study.
Nolasco-Quintana NY; González-Maya L; Razo-Hernández RS; Alvarez L
Mol Inform; 2023 Jan; 42(1):e2200016. PubMed ID: 36065495
[TBL] [Abstract][Full Text] [Related]
2. Finding a Novel Chalcone-Cinnamic Acid Chimeric Compound with Antiproliferative Activity against MCF-7 Cell Line Using a Free-Wilson Type Approach.
Ventura-Salazar IAY; Palacios-Can FJ; González-Maya L; Sánchez-Carranza JN; Antunez-Mojica M; Razo-Hernández RS; Alvarez L
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513358
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
[TBL] [Abstract][Full Text] [Related]
5. Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity.
Luo Y; Zhou Y; Song Y; Chen G; Wang YX; Tian Y; Fan WW; Yang YS; Cheng T; Zhu HL
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3634-3638. PubMed ID: 30389289
[TBL] [Abstract][Full Text] [Related]
6. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
7.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
8. Novel cinnamic acid derivatives as antioxidant and anticancer agents: design, synthesis and modeling studies.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Geromichalos G
Molecules; 2014 Jul; 19(7):9655-74. PubMed ID: 25004073
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.
Yang XH; Wen Q; Zhao TT; Sun J; Li X; Xing M; Lu X; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(3):1181-7. PubMed ID: 22261027
[TBL] [Abstract][Full Text] [Related]
10. Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies.
Molnar M; Lončarić M; Opačak-Bernardi T; Glavaš-Obrovac L; Rastija V
Anticancer Agents Med Chem; 2023; 23(7):839-846. PubMed ID: 36305127
[TBL] [Abstract][Full Text] [Related]
11. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
Yadav D; Nath Mishra B; Khan F
J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Pyrrolo[3,4-
Segura-Olvera D; García-González AN; Morales-Salazar I; Islas-Jácome A; Rojas-Aguirre Y; Ibarra IA; Díaz-Cervantes E; Alcaraz-Estrada SL; González-Zamora E
Molecules; 2019 Jul; 24(14):. PubMed ID: 31336585
[TBL] [Abstract][Full Text] [Related]
15. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Wang SF; Yin Y; Zhang YL; Mi SW; Zhao MY; Lv PC; Wang BZ; Zhu HL
Eur J Med Chem; 2015 Mar; 93():291-9. PubMed ID: 25703297
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents.
Qian Y; Zhang HJ; Zhang H; Xu C; Zhao J; Zhu HL
Bioorg Med Chem; 2010 Jul; 18(14):4991-6. PubMed ID: 20594859
[TBL] [Abstract][Full Text] [Related]
18. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
Jarapula R; Badavath VN; Rekulapally S; Manda S
Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
[TBL] [Abstract][Full Text] [Related]
19. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
Mitra I; Saha A; Roy K
J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
[TBL] [Abstract][Full Text] [Related]
20. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]